gdc
Lung Cancer

A Welcomed Mutation? Don Cook Is Living One Day at a Time with ALK-Positive Lung Cancer

Don Cook felt he had a second chance at life when he learned that his lung cancer had a genetic alternation known as ALK mutation, for which targeted therapies are available today.
November 2018 Volume 4 – Lung Cancer
Kelsey Moroz

It was Friday afternoon around 3 o’clock when the phone in Don and Diana Cook’s living room rang. The person on the other end had only one thing to say—Don’s non–small-cell lung cancer, or NSCLC, had tested positive for the genetic ALK mutation (genetic abnormality). As Don hung up the phone, his family ran around the house in celebration.

Recommended For You
ImmunotherapyMultiple Myeloma
How CAR T-Cell Therapy Gave Cherie Rineker Her Life Back
By Kelsey Moroz
Chemotherapy for multiple myeloma had kept Cherie Rineker alive for 5 years, but then she realized she was slowly dying. So she embarked on a search for a clinical trial and by luck was able to join one. To her amazement, “What 2 stem-cell transplants and 13 other treatments had not been able to do in more than 65 months, CAR T-cell therapy did in less than 1 month,” she said.
Cancer ResearchSurvivorship
The Link between Obesity and Cancer
By Kelsey Moroz
Obesity is associated with about 40% of cancers in the United States. This link is strongest in several types of cancer, including kidney, gastric, pancreatic, endometrial, and esophageal cancer. Significant weight reduction may help to reduce the risk for cancer.
Last modified: January 4, 2019

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country